Acquired perforating dermatosis in patients with chronic renal failure and diabetes mellitus

Journal of Korean Medical Science

Volumn 19, Issue 2, 2004, Pages 283-288

  Hong, Seok Beom ^a   Park, Jung Hun ^a   Ihm, Chun Gyoo ^a   Kim, Nack In ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Acquired Perforating Dermatosis; Diabetes Mellitus; Kidney Failure, Chronic; Skin Diseases

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATOSIS; MALE; PAPULE; PATHOGENESIS; PERFORATION; PRURITUS; SCRATCHING; SKIN DISEASE; SKIN NODULE;

EID: 2342638833     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.2.283     Document Type: Article

References (23)

1. Maurice PD. Acquired perforating dermatosis in renal patients. Nephrol Dial Transplant 1997; 12: 2774-5.
2. Kawakami T, Saito R. Acquired reactive perforating collagenosis associated with diabetes mellitus: eight cases that meet Faver's criteria. Br J Dermatol 1999; 140: 521-4.
3. Poliak SC, Lebwohl MG, Parris A, Prioleau PG. Reactive perforating collagenosis associated with diabetes mellitus. N Engl J Med 1982; 306: 81-4.
4. Cochran RJ, Tucker SB, Wilkin JK. Reactive perforating collagenosis of diabetes mellitus and renal failure. Cutis 1983; 31: 55-8.
5. Rapini RP, Herbert AA, Drucker CR. Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol 1989; 125: 1074-8.
6. Heilman ER, Friedman RJ. In, Lever's Histopathology of the Skin (Elder D, ed). Lippincott-Raven, Philadelphia 1997: 341-51.
7. Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. Acquired perforating dermatosis in renal failure. Korean J Dermatol 2000; 38: 1157-61.
8. Bang SW, Bu TS, Hyun C, Whang KU, Kim YK. Four cases of acquired perforating disease in patients with chronic renal failure. Korean J Dermatol 1997; 35: 333-8.
9. Morton CA, Henderson IS, Jones MC, Lowe JG. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 1996; 135: 671-7.
10. Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis: report of six cases and review of the literature. J Am Acad Dermatol 1994; 30: 575-80.
11. Pedragosa R, Knobel HJ, Huguet P, Oristrell J, Values M, Bosch JA. Reactive perforating collagenosis with Hodgkin's disease. Am J Dermatopathol 1987; 9: 41-4.
12. Mehregan AH. Elastosis perforans serpiginosa: a review of the literature and report of 11 cases. Arch Dermatol 1968; 97: 381-93.
13. Yuzuk S, Trau H, Stempler D, Sofer E, Levy A, Schewach-Millet M. Reactive perforating collagenosis. Int J Dermatol 1985; 24: 584-6.
14. Denman ST. A review of pruritus. J Am Acad Dermatol 1986; 14: 375-92.
15. Cohen RW, Auerbach R. Acquired reactive perforating collagenosis. J Am Acad Dermatol 1989; 20: 287-9.
16. Ponticelli C, Bencini PL. Uremic pruritus: a review. Nephron 1992; 60: 1-5.
17. Bayoumi AH, Gaskell S, Marks R. Development of a model for transepidermal elimination. Br J Dermatol 1978; 99: 611-20.
18. Patterson JW, Brown PC. Ultrastructural changes in acquired perforating dematosis. IntJDermatol 1992; 31: 201-5.
19. Hood A, Hardegen GL, Zarate AR, Nigra TP, Gelfand MC. Kyrle's disease in patients with chronic renal failure. Arch Dermatol 1982; 118: 85-8.
20. Bank DE, Cohen PR, Kohn SR. Reactive perforating collagenosis in a setting of double disaster: acquired immunodeficiency syndrome and end-stage renal disease. J Am Acad Dermatol 1989; 21: 371-4.
21. Stone RA. Kyrle-like lesions in two patients with renal failure undergoing dialysis. J Am Acad Dermatol 1981; 5: 707-9.
22. Blanchley JD, Blankenship M, Menter A. Uremic pruritus: skin divalent ion content and response to ultraviolet therapy. Am J Kidney Dis 1985; 5: 237-41.
23. Haftek M, Euvrard S, Kanitakis J, Delawari E, Schmitt D. Acquired perforating dermatosis of diabetes mellitus and renal failure: further ultrastructural clues to its pathogenesis. J Cutan Pathol 1993; 20: 350-5.